English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 54 Help

Selected(0)Clear Items/Page:    Sort:
Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma Journal article
Zou, Huimin, Lai, Yunfeng, Chen, Xianwen, Ung, Carolina Oi Lam, Hu, Hao. Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma[J]. Therapeutic Advances in Gastroenterology, 2025, 18, 1-13.
Authors:  Zou, Huimin;  Lai, Yunfeng;  Chen, Xianwen;  Ung, Carolina Oi Lam;  Hu, Hao
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.9/4.0 | Submit date：2025/01/22
Camrelizumab  Cost-effectiveness Analysis  Hepatocellular Carcinoma  Partitioned Survival Model  Rivoceranib  
Guiding induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma with ternary classification of predicted individual treatment effect Journal article
Zhiying Liang, Kit Ian Kou, Chao Luo, Shuqi Li, Yuliang Zhu, Wenjie Huang, Di Cao, Yifei Liu, Guangying Ruan, Shaobo Liang, Xi Chen, Guoyi Zhang, Lizhi Liu, Haojiang Li. Guiding induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma with ternary classification of predicted individual treatment effect[J]. Radiotherapy and Oncology, 2024, 201, 110571.
Authors:  Zhiying Liang;  Kit Ian Kou;  Chao Luo;  Shuqi Li;  Yuliang Zhu; et al.
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.9/5.4 | Submit date：2024/10/16
Nasopharyngeal Carcinoma  Induction Chemotherapy  Overall Survival  Treatment Decision-making  Predicted Individual Treatment Effect  
The impact of cysteine on lifespan in three model organisms: A systematic review and meta-analysis Journal article
Ma, Yue, Chen, Mengqi, Huang, Kaiyao, Chang, Wakam. The impact of cysteine on lifespan in three model organisms: A systematic review and meta-analysis[J]. Aging Cell, 2024, e14392.
Authors:  Ma, Yue;  Chen, Mengqi;  Huang, Kaiyao;  Chang, Wakam
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:8.0/9.7 | Submit date：2024/12/05
Aging  Anti-aging  Cysteine  Lifespan  Nac  Survival  
Multimodal Machine Learning for Prognosis and Survival Prediction in Renal Cell Carcinoma Patients: A Two-Stage Framework with Model Fusion and Interpretability Analysis Journal article
Yan, Keyue, Fong, Simon, Li, Tengyue, Song, Qun. Multimodal Machine Learning for Prognosis and Survival Prediction in Renal Cell Carcinoma Patients: A Two-Stage Framework with Model Fusion and Interpretability Analysis[J]. APPLIED SCIENCES-BASEL, 2024, 14(13), 5686.
Authors:  Yan, Keyue;  Fong, Simon;  Li, Tengyue;  Song, Qun
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:2.5/2.7 | Submit date：2024/08/05
Machine Learning  Multimodal Data  Renal Cell Carcinoma  Survival Prediction  
Prediction analysis of TBI 24-h survival outcome based on machine learning Journal article
Yang, Yang, Zhou, Liulei, Luo, Jinhua, Xue, Jianhua, Liu, Jiajia, Zhang, Jiajia, Wang, Ziheng, Gong, Peipei, Chen, Tianxi. Prediction analysis of TBI 24-h survival outcome based on machine learning[J]. Heliyon, 2024, 10(9), e30198.
Authors:  Yang, Yang;  Zhou, Liulei;  Luo, Jinhua;  Xue, Jianhua;  Liu, Jiajia; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.4/3.9 | Submit date：2024/05/16
Dnn  Knn  Lr  Machine Learning  Rf  Survival  Trauma  
Optimal Size Threshold for MRI-Detected Retropharyngeal Lymph Nodes to Predict Outcomes in Nasopharyngeal Carcinoma: A Two-Center Study Journal article
Zhu, Yuliang, Luo, Chao, Zhou, Shumin, Li, Haojiang, Liu, Lizhi, Kou, Kit Ian, Lei, Feng, Zhang, Guoyi, Cao, Di, Liang, Zhiying. Optimal Size Threshold for MRI-Detected Retropharyngeal Lymph Nodes to Predict Outcomes in Nasopharyngeal Carcinoma: A Two-Center Study[J]. American Journal of Roentgenology, 2024, 222(1), e2329984.
Authors:  Zhu, Yuliang;  Luo, Chao;  Zhou, Shumin;  Li, Haojiang;  Liu, Lizhi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:4.7/4.1 | Submit date：2024/02/22
Minimal Axial Diameter  Nasopharyngeal Carcinoma  Prognosis  Progression-free Survival  Retropharyngeal Lymph Node  
Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer Journal article
Li, Yulei, Zhang, Lulu, Xu, Gang, Chen, Jiajun, Zhao, Keyuan, Li, Mengyao, Jin, Jing, Peng, Chao, Wang, Kaifang, Pan, Shouhua, Zhu, Ke. Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer[J]. Frontiers in Immunology, 2024, 15, 1493528.
Authors:  Li, Yulei;  Zhang, Lulu;  Xu, Gang;  Chen, Jiajun;  Zhao, Keyuan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.7/6.8 | Submit date：2025/01/13
Akr1b1  Bladder Cancer  Chemotherapy Response  Overall Survival  Prognostic Signature  Reactive Oxygen Species  
Coculture of cancer cells with platelets increases their survival and metastasis by activating the TGFβ/Smad/PAI-1 and PI3K/AKT pathways Journal article
Tong, Haibo, Li, Koukou, Zhou, Muya, Wu, Ranfei, Yang, Hongmei, Peng, Zheng, Zhao, Qi, Luo, Kathy Qian. Coculture of cancer cells with platelets increases their survival and metastasis by activating the TGFβ/Smad/PAI-1 and PI3K/AKT pathways[J]. International Journal of Biological Sciences, 2023, 19(13), 4259-4277.
Authors:  Tong, Haibo;  Li, Koukou;  Zhou, Muya;  Wu, Ranfei;  Yang, Hongmei; et al.
Favorite | TC[WOS]:8 TC[Scopus]:12  IF:8.2/8.3 | Submit date：2023/08/23
Cancer Cells  Platelets  Survival  Metastasis  Tgfβ  Pai-1  
Kill Stories: A Critical Narrative in the Zhuangzi. Journal article
Hans-Georg Moeller. Kill Stories: A Critical Narrative in the Zhuangzi.[J]. Dao: A Journal of Comparative Philosophy, 2023, 22(3), 397 - 412.
Authors:  Hans-Georg Moeller
Adobe PDF | Favorite | TC[WOS]:0 TC[Scopus]:0  IF:0.5/0.5 | Submit date：2023/08/08
Zhuangzi 莊子  Daoism  Ritual  Kill Stories  Confucianism  Survival Stories  
Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients with Stage IV Colorectal Cancer after Surgery Journal article
Wang, Ting, Tang, Yuting, Pan, Wenjun, Yan, Botao, Hao, Yifan, Zeng, Yunli, Chen, Zexin, Lan, Jianqiang, Zhao, Shuhan, Deng, Chuxia, Zheng, Hang, Yan, Jun. Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients with Stage IV Colorectal Cancer after Surgery[J]. Diseases of the Colon and Rectum, 2023, 66(5), 733-743.
Authors:  Wang, Ting;  Tang, Yuting;  Pan, Wenjun;  Yan, Botao;  Hao, Yifan; et al.
Favorite | TC[WOS]:11 TC[Scopus]:10  IF:3.2/4.0 | Submit date：2023/06/05
Drug Tests  Patient-derived Tumor Organoid  Predictive Model  Prognostic Value  Progression-free Survival  Stage Iv Colorectal Cancer